P04-26. Immunological tolerance prevents the expression of a broadly reactive neutralizing HIV-1 antibody

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1742-4690

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: P04-26. Immunological tolerance prevents the expression of a broadly reactive neutralizing HIV-1 antibody ; volume:6 ; number:3 ; day:22 ; month:10 ; year:2009 ; pages:1 ; date:10.2009
Retrovirology ; 6, Heft 3 (22.10.2009), 1, 10.2009

Creator: Verkoczy, L.

Contributor: Diaz, M.
Holl, TM
Ouyang, Y.
Bouton-Verville, H.
Alam, SM
Liao, H.
Kelsoe, G.
Haynes, BF
SpringerLink (Online service)

DOI: 10.1186/1742-4690-6-S3-P54

URN: urn:nbn:de:1111-201608078754

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Verkoczy, L.
Diaz, M.
Holl, TM
Ouyang, Y.
Bouton-Verville, H.
Alam, SM
Liao, H.
Kelsoe, G.
Haynes, BF
SpringerLink (Online service)

Other Objects (12)

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

Broadly Neutralizing Antibodies for HIV Eradication

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Design clues from functional constraints and broadly neutralizing antibodies

Vaccination induces broadly neutralizing antibody precursors to HIV gp41

A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages

Hochschulschrift

Identification and characterization of broadly neutralizing antibodies targeting viral infections

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

HIV-1 cell-to-cell transmission and broadly neutralizing antibodies

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

Broadly Neutralizing Antibodies for HIV Eradication

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Design clues from functional constraints and broadly neutralizing antibodies

Vaccination induces broadly neutralizing antibody precursors to HIV gp41

A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages

Hochschulschrift

Identification and characterization of broadly neutralizing antibodies targeting viral infections

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

HIV-1 cell-to-cell transmission and broadly neutralizing antibodies

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

Broadly Neutralizing Antibodies for HIV Eradication

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Design clues from functional constraints and broadly neutralizing antibodies

Vaccination induces broadly neutralizing antibody precursors to HIV gp41

A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages

Hochschulschrift

Identification and characterization of broadly neutralizing antibodies targeting viral infections

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

HIV-1 cell-to-cell transmission and broadly neutralizing antibodies

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

P04-26. Immunological tolerance prevents the expression of a broadly reactive neutralizing HIV-1 antibody

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

Broadly Neutralizing Antibodies for HIV Eradication

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Design clues from functional constraints and broadly neutralizing antibodies

Vaccination induces broadly neutralizing antibody precursors to HIV gp41

A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages

Identification and characterization of broadly neutralizing antibodies targeting viral infections

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

HIV-1 cell-to-cell transmission and broadly neutralizing antibodies

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

Broadly Neutralizing Antibodies for HIV Eradication

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Design clues from functional constraints and broadly neutralizing antibodies

Vaccination induces broadly neutralizing antibody precursors to HIV gp41

A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages

Identification and characterization of broadly neutralizing antibodies targeting viral infections

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

HIV-1 cell-to-cell transmission and broadly neutralizing antibodies

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

Broadly Neutralizing Antibodies for HIV Eradication

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Design clues from functional constraints and broadly neutralizing antibodies

Vaccination induces broadly neutralizing antibody precursors to HIV gp41

A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages

Identification and characterization of broadly neutralizing antibodies targeting viral infections

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

HIV-1 cell-to-cell transmission and broadly neutralizing antibodies

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

Related objects

Reset password